We deliver evidence-based public health interventions across Leprosy, Tuberculosis, NTDs, and Mental Health for vulnerable communities

A 4-arm cluster-randomized trial evaluating the feasibility and acceptability of combining primary mental health counselling and self-care interventions led by trained volunteer NTD Champions across endemic local government areas.

Cluster-randomized clinical trial measuring the clinical and psychosocial impact of community advocacy, healthcare worker training, and peer self-help groups for persons affected by debilitating skin diseases.

Integrated Single-Dose Rifampicin Post-Exposure Prophylaxis (SDR-PEP) into national leprosy strategies, establishing systematic household and neighbor contact screening protocols to intercept transmission early.

Comprehensive implementation science program encompassing INSTIL (community ulcer self-care), HABU (Buruli ulcer clinical needs), and SUSTAIN (evaluating sustainability of donor-funded self-help groups).

Pioneered systemic integration of the Mental Health Care Action Programme (mhCAP) into leprosy and skin-NTD clinical services, conducting 15,000+ PHQ-9 depression assessments, training 320+ primary health staff, and linking 4,800+ patients to structured psychosocial support.

Bridged health and development information gaps among illiterate women and girls in Southeast Nigeria through accessible smartphone audio health messaging.

Expanded TB services among formal and informal private providers, patent medicine vendors (PPM), and faith-based institutions across priority operational states, contributing to 437,895 target notifications.

Increased TB case notifications by expanding diagnostic referral networks and training frontline healthcare workers across public and private clinics.

Targeted direct relief and cash transfers to persons with disabilities (PWDs) and persons affected by leprosy and Buruli ulcer across referral hospital clusters and CBID pilot LGAs during the pandemic.

Evaluated the socioeconomic impact of the COVID-19 pandemic and assessed levels of stigma and discrimination against persons affected by leprosy and their families in Southern Nigeria.

Deployed LGA cluster case-finding, output-based stipends, reconstructive surgeries, educational support for school-age children, and mobile mHealth tele-dermatology diagnosis across endemic communities.

Global and national advocacy campaign protecting human rights, preventing neglect of leprosy care, and eliminating societal discrimination during pandemic response.

Strengthened disabled persons organizations (JONAPWD) and IDEA to promote the Disability Rights Act, establish leprosy self-help associations, conduct accessibility surveys, and mentor DPOs in grant writing.

Scaled Private-Public Mix (PPM) engagement across private hospitals, faith-based facilities, community pharmacies, and patent medicine vendors, raising PPM TB case notification contribution from 11% to 35%.

Tri-disease intervention across 11 states increasing early leprosy detection, halving Grade-2 disability rates, expanding GeneXpert lab power resilience, and establishing integrated NTD morbidity management.

Strengthened primary healthcare DOTS treatment expansion and clinical specimen referral pathways in underserved LGAs.

Morbidity Management and Disability Prevention (MMDP) focusing on self-care, output-based school skin screening camps, and community hygiene packs in endemic LGAs.

Community-based drug-resistant TB (DR-TB) ambulatory care management, LGA team training, quarterly state review committees, and cold-chain sputum specimen transport coordination.

National strategic TB/HIV case finding, diagnostic scaling, and MDR-TB prevention grant closing detection gaps across non-DOTS communities.

Provided clinical MMDP capacity training to health workers and community self-care groups in Ogbaru LGA for lymphedema, Buruli ulcer wound dressing, and complication management.